Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Spironolactone can cause side effects like high potassium levels and breast enlargement, and patients need careful monitoring.

In 2002, various skin reactions were reported due to different drugs, including allergies, hair loss, skin lesions, and other skin conditions.

Larger ovarian size is linked to higher insulin resistance in women with PCOS.

Many infertile women with PCOS in Central Vietnam have metabolic or insulin resistance syndrome, with obesity and older age increasing the risk.

Human hair protein modifications could potentially indicate heart disease risk.

Possible link between hair loss and metabolic syndrome, with RANTES as a potential clue.

Women with PCOS have heart-related issues not because of obesity, but due to insulin resistance and low adiponectin levels.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Vitamins A, B3, C, D, and E can improve skin health and immunity.

Topical metformin shows promise for treating skin conditions like acne and psoriasis.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Lower doses of treatments for hirsutism and acne in PCOS are effective and cause fewer side effects.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

Women with PCOS have more body fat and thicker fat layers in certain abdominal areas than women without PCOS.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Hormonal treatments can help with acne, especially in women, by lowering androgen levels or blocking their effects.

Women with PCOS often have skin problems like excessive hair, acne, hair loss, and dark patches, which can be treated with hormonal and non-hormonal therapies.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

ARL15 is important for fat cell development and the release of the hormone adiponectin.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

PCOS is diagnosed when at least two of these three features are present: polycystic ovaries, irregular ovulation, and high androgen levels.

Apigenin and ellagic acid may help manage PCOS symptoms.

Reducing iron levels didn't improve heart health or metabolism in women with certain ovarian issues.

There is no cure for myotonic dystrophy type 1, so treatment focuses on managing symptoms and complications.

PROMETHEUS helps organize and evaluate causal claims from large language models.

Polycystic Ovary Syndrome should be seen mainly as a condition of excess male hormones, with a focus on this in its definition.

The Rotterdam Study investigates diseases in older adults and has produced many research findings.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The document concludes that PCOS is a complex disorder caused by both genetic and environmental factors, affecting women's health in various ways, and requires personalized treatment.